alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Abril de 2020

3 consejos para personas inscritas en el 

Programa para Beneficiarios Calificados de 

Medicare

Si se encuentra entre los 7.5 millones de personas inscritas en el Programa 

para Beneficiarios Calificados de Medicare (QMB en inglés), los proveedores 

de Medicare no pueden facturarle los servicios y artículos que cubre Medicare, 

incluidos los deducibles, coseguros y copagos. Si un proveedor le pide que pague 

alguna de estas cantidades, eso está en contra de la ley. 

Si recibe una factura por estos cargos:

1. Dígale a su proveedor o al cobrador de deudas que está inscrito en el 

Programa QMB y no puede cobrar por los deducibles, coseguros y copagos de 

Medicare. Si ya ha realizado pagos de una factura por servicios y artículos que 

cubre Medicare, tiene derecho a un reembolso. 

Nota: para asegurarse de que su proveedor conozca que está en el Programa 

QMB, muestre su tarjeta de Medicare y Medicaid o QMB cada vez que reciba 

atención. También puede darle a su proveedor una copia de su Aviso de 

Resumen de Medicare (MSN en inglés). Su MSN le mostrará que está en el 

programa QMB y no deben facturarle. Inicie sesión en su cuenta 

MyMedicare.gov en cualquier momento para ver su MSN o regístrese para 

obtener sus MSN electrónicamente.

2. Si su proveedor no deja de facturarle, llámenos al 1-800-MEDICARE 

(1-800-633-4227). Los usuarios de TTY pueden llamar al 1-877-486-2048. 

Podemos confirmar que está en el programa QMB. También podemos pedirle 

a su proveedor que deje de facturarle y reembolsarle cualquier pago que ya 

haya realizado. 

3. Si tiene un problema con un cobrador de deudas, puede enviar una queja a 

la Oficina de Protección Financiera del Consumidor (CFPB en inglés) en línea 

o llamar al número gratuito de CFPB al (855) 411-2372. Los usuarios de TTY 

pueden llamar al (855) 729-2372. CFPB enviará su queja a la compañía de 

cobro de deudas y trabajará para obtener una respuesta de ellos. 
CMS Producto No.12039-S

Usted tiene derecho a obtener la información de Medicare en un formato accesible 

como letra grande, Braille o audio. También tiene el derecho de presentar una 

queja si piensa que ha sido discriminado. Visite https://www.cms.gov/about-cms/

agency-information/aboutwebsite/cmsnondiscriminationnotice.html o llame al 

1-800-MEDICARE (1-800-633-4227) para obtener más información. Los usuarios de 

TTY pueden llamar al 1-877-486-2048. 

Pagado por el Departamento de Salud y Servicios Humanos.
I 

118TH CONGRESS 

2D SESSION H. R. 7290 

To prohibit corruption in the office of any State or local chief prosecutor. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 7, 2024 

Mr. MILLS (for himself, Mr. MCCORMICK, and Mr. DONALDS) introduced the 

following bill; which was referred to the Committee on the Judiciary 

A BILL 

To prohibit corruption in the office of any State or local 

chief prosecutor. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Against Federal Funds 

5 for Allowing Inappropriate Relationships Act’’ or the ‘‘AF6 FAIR Act’’. 

7 SEC. 2. PROHIBITION. 

8 No Federal funds may be awarded to the office of 

9 any State or local chief prosecutor if any individual in such 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7290 IH

1 office has been convicted for engaging corruption or any 

2 other unlawful activity. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
Filed: November 5, 1998 UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 97-7871 (CA-97-159-5-21)
ALLEN POWERSTEIN, Plaintiff - Appellant, versus FEDERAL BUREAU OF PRISONS; M. E. RAY, Warden; M. RICHER, Associate Warden; KAPUSTA, Camp Administrator; C. CRAWFORD, Captain; R. MOORE, Unit Manager; M. CAMPBELL, Unit Manager; J. TUDOR, Lieutenant; ALSTON, Case Manager, VAN DIVER, Counselor; THREE UNKNOWN, UNIDENTIFIED INMATES, 

### Defendants - Appellees.

ORDER The court amends its opinion filed October 7, 1998, as follows:On the cover sheet, section 2, lines 4-5 -- "J. TUDOR, Lieutenant; ALSTON, Case Manager" are added to correct the caption. For the Court - By Direction

/s/ Patricia S. Connor Clerk2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 97-7871
ALLEN POWERSTEIN, Plaintiff - Appellant, versus FEDERAL BUREAU OF PRISONS; M. E. RAY, Warden; M. RICHER, Associate Warden; KAPUSTA, Camp Administrator; C. CRAWFORD, Captain; R. MOORE, Unit Manager; M. CAMPBELL, Unit Manager; J. TUDOR, Lieutenant; ALSTON, Case Manager, VAN DIVER, Counselor; THREE UNKNOWN, UNIDENTIFIED INMATES, Defendants - Appellees. Appeal from the United States District Court for the District of South Carolina, at Orangeburg. William B. Traxler, Jr., District Judge. (CA-97-159-5-21) Submitted: September 22, 1998 Decided: October 7, 1998 Before ERVIN, WILKINS, and MICHAEL, Circuit Judges. Affirmed by unpublished per curiam opinion. Allen Powerstein, Appellant Pro Se. Barbara Murcier Bowens, OFFICE OF THE UNITED STATES ATTORNEY, Columbia, South Carolina, for Appellees.3 Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).* Although Powerstein’s claim was filed under S 1983, the district court properly construed it as one under Bivens v. Six Unknown Named Agents of Federal Bureau of Narcotics, 403 U.S. 388 (1971). 4 PER CURIAM: Allen Powerstein appeals the district court’s order denyingrelief on his 42 U.S.C.A. S 1983 (West 1994 & Supp. 1998) complaint.* We have reviewed the record and the district court’s opinion accepting the magistrate judge’s recommendation and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Powerstein v. Federal Bureau of Prisons, No. CA-97- 159-5-21 (D.S.C. Dec. 11, 1997). We dispense with oral argument because the facts and legal contentions are adequately presented inthe materials before the court and argument would not aid the decisional process.

AFFIRMED
[No. 16155-2-III.

Division Three.

December 23, 1997.]

#### The State of Washington, *Respondent,*v. Daniel J. Sapp, *Appellant.*

Appeal from a judgment of the Superior Court for Douglas County, No. 96-1-00054-3, Ted W. Small, J., entered October 1, 1996. *Affirmed*by unpublished opinion per Sweeney, C.J., concurred in by Kurtz and Kato, JJ.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7192 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 466
118th CONGRESS
  2d Session
                                H. R. 7192

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              June 4, 2024

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

                             August 1, 2024

               Reported by Mr. Peters, without amendment

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
 at 333 West Broadway in Anaheim, California, as the ``Dr. William I. 
                  `Bill' Kott Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DR. WILLIAM I. ``BILL'' KOTT POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 333 West Broadway in Anaheim, California, shall be known and 
designated as the ``Dr. William I. `Bill' Kott Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Dr. 
William I. `Bill' Kott Post Office Building''.
                                                       Calendar No. 466

118th CONGRESS

  2d Session

                               H. R. 7192

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
 at 333 West Broadway in Anaheim, California, as the ``Dr. William I. 
                  `Bill' Kott Post Office Building''.

_______________________________________________________________________

                             August 1, 2024

                       Reported without amendment
```
[No. 38567-4-I.

Division One.

December *1,*1997.]

#### The State of Washington, *Respondent,*v. Kenneth Clemons, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-1-00202-6, Steven G. Scott, J., entered May 6, 1996. *Affirmed*by unpublished per curiam opinion.
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





|In connection with the annual report of Naturewell, Incorporated (the "Registrant") on Form 10-K for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report") the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|                                                                                                                                                                                                                                                                                                                                                                                                       
|                                                                                                                                                                                                                                                                                                                                                                                                       
|                                                                                                                                                                                                                                                                                                                                                                                                       
|Dated:  October 13, 2011
#### MARIE BOWER, RESPONDENT, v. METAL COMPOUND CORPORATION, APPELLANT.

Submitted February 17, 1939

Decided April 21, 1939.

For the respondent, *Braff & Litvak.*

For the appellant, *Cox Walburg.*

Per Curiam.

The judgment under review herein should be affirmed, for the reasons expressed in the opinion delivered by Mr. Justice Bodine in the Supreme Court.

*For affirmance*— The Chancellor, Parker, Case, Donges, Perskie, Porter, Hetfield, Dear, Wells, WolfsKeil, Rafferty, Hague, JJ. 12.

*For reversal*— Hone.
§ 1316.09 Application for administrative inspection warrant. ( a ) An administrative inspection warrant application shall be submitted to any judge of the United States or of a State court of record, or any United States magistrate and shall contain the following information: ( 1 ) The name and address of the controlled premises to be inspected;
( 2 ) A statement of statutory authority for the administrative inspection warrant, and that the fact that the particular inspection in question is designed to insure compliance with the Act and the regulations promulgated thereunder;
( 3 ) A statement relating to the nature and extent of the administrative inspection, including, where necessary, a request to seize specified items and/or to collect samples of finished or unfinished controlled substances or listed chemicals;
( 4 ) A statement that the establishment either: ( i ) Has not been previously inspected, or
( ii ) Was last inspected on a particular date.
( b ) The application shall be submitted under oath to an appropriate judge or magistrate.
[36 FR 7820, Apr. 24, 1971, as amended at 36 FR 13387, July 21, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973; 60 FR 32466, June 22, 1995]
§ 182.1781 Sodium aluminum phosphate. ( a ) *Product.* Sodium aluminum phosphate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing practice.
NO UN P UB L I S HE D O P INI ON S F IL E D T OD AY .
[Nos. 21126-2-II; 21127-1-II; 21128-9-II; 21129-7-II; 21130-1-II; 21131-9-II.

Division Two.

January 16, 1998.]

#### The State of Washington, *Respondent,*v. Christopher Neil Nordquist, *Appellant.*

Appeals from judgments of the Superior Court for Cowlitz County, Nos. 86-1-00171-6; 87-1-00379-2; 88-1-00352-9; 90-1-00396-2; 92-1-00254-7; 88-1-00373-1, James E.F.X. Warme, J., entered August 13, 1996. *Affirmed in part*and *remanded*by unpublished opinion per Houghton, C.J., concurred in by Morgan and Hunt, JJ.
Exhibit 32 (b)
 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Form 10-Q fully complies with the requirements of Section 13 (a) or
(15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78(d)); and(2)
    
    The information contained in the Form 10-Q fairly presents in all
material respects, the financial condition and results of operations of the
Partnership.
 Date: 5-14-10
 
 A signed original of this written statement required by Section 906 has been provided to
Northland Cable Properties Seven Limited Partnership and will be retained by Northland Cable
Properties Seven Limited Partnership and furnished to the Securities and Exchange Commission or its
staff upon request.
§ 211.101 Charge-in of components. Written production and control procedures shall include the following, which are designed to assure that the drug products produced have the identity, strength, quality, and purity they purport or are represented to possess: ( a ) The batch shall be formulated with the intent to provide not less than 100 percent of the labeled or established amount of active ingredient.
( b ) Components for drug product manufacturing shall be weighed, measured, or subdivided as appropriate. If a component is removed from the original container to another, the new container shall be identified with the following information: ( 1 ) Component name or item code;
( 2 ) Receiving or control number;
( 3 ) Weight or measure in new container;
( 4 ) Batch for which component was dispensed, including its product name, strength, and lot number.
( c ) Weighing, measuring, or subdividing operations for components shall be adequately supervised. Each container of component dispensed to manufacturing shall be examined by a second person to assure that: ( 1 ) The component was released by the quality control unit;
( 2 ) The weight or measure is correct as stated in the batch production records;
( 3 ) The containers are properly identified. If the weighing, measuring, or subdividing operations are performed by automated equipment under § 211.68, only one person is needed to assure paragraphs (c)(1), (c)(2), and (c)(3) of this section.
( d ) Each component shall either be added to the batch by one person and verified by a second person or, if the components are added by automated equipment under § 211.68, only verified by one person.
[43 FR 45077, Sept. 29, 1978, as amended at 73 FR 51932, Sept. 8, 2008]
Editorial Note on Part 201
Editorial Note: Nomenclature changes to part 201 appear at 69 FR 13717, Mar. 24, 2004.

§ 201.316 Drugs with thyroid hormone activity for human use; required warning. ( a ) Drugs with thyroid hormone activity have been promoted for, and continue to be dispensed and prescribed for, use in the treatment of obesity, although their safety and effectiveness for that use have never been established.
( b ) Drugs for human use with thyroid hormone activity are misbranded within the meaning of section 502 of the Federal Food, Drug, and Cosmetic Act unless their labeling bears the following boxed warning at the beginning of the “Warnings” section:
Drugs with thyroid hormone activity, alone or together with other therapeutic agents, have been used for the treatment of obesity. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. [43 FR 22009, May 23, 1978]
H. Res. 469 

In the House of Representatives, U. S., 

July 24, 2017. 

Resolved, That the Clerk of the House of Representatives 

request the Senate to return to the House the joint resolution 

(H.J. Res. 76) entitled ‘‘Granting the consent and approval 

of Congress for the Commonwealth of Virginia, the State of 

Maryland, and the District of Columbia to a enter into a 

compact relating to the establishment of the Washington 

Metrorail Safety Commission.’’. 

Attest: 

Clerk.
H. R. 7192 

One Hundred Eighteenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Wednesday, 

the third day of January, two thousand and twenty-four 

An Act 

To designate the facility of the United States Postal Service located at 333 West 

Broadway in Anaheim, California, as the ‘‘Dr. William I. ‘Bill’ Kott Post Office 

Building’’. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. DR. WILLIAM I. ‘‘BILL’’ KOTT POST OFFICE BUILDING. 

(a) DESIGNATION.—The facility of the United States Postal 

Service located at 333 West Broadway in Anaheim, California, 

shall be known and designated as the ‘‘Dr. William I. ‘Bill’ Kott 

Post Office Building’’. 

(b) REFERENCES.—Any reference in a law, map, regulation, 

document, paper, or other record of the United States to the facility 

referred to in subsection (a) shall be deemed to be a reference 

to the ‘‘Dr. William I. ‘Bill’ Kott Post Office Building’’. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.808 Copolymer condensates of ethylene oxide and propylene oxide. Copolymer condensates of ethylene oxide and propylene oxide may be safely used in food under the following prescribed conditions: ( a ) The additive consists of one of the following: ( 1 ) α-Hydro-*omega*-hydroxy-poly (oxyethylene) poly(oxypropylene)-(55-61 moles)poly(oxyethylene) block copolymer, having a molecular weight range of 9,760-13,200 and a cloud point above 100 °C in 1 percent aqueous solution.
( 2 ) α-Hydro*-omega-*hydroxy-poly (oxyethylene)poly(oxypropylene)-(53-59 moles)poly(oxyethylene)(14-16 moles) block copolymer, having a molecular weight range of 3,500-4,125 and a cloud point of 9 °C-12 °C in 10 percent aqueous solution.
( 3 ) α-Hydro-*omega*-hydroxy-poly(ox-yethylene)/poly(oxypropylene) (minimum 15 moles)/poly(oxyethylene) block copolymer, having a minimum average molecular weight of 1900 and a minimum cloud point of 9 °C-12 °C in 10 percent aqueous solution.
( 4 ) α-Hydro-*omega*-hydroxy-poly(ox-yethylene) poly (oxypropylene)-(51-57 moles) poly(oxyethylene) block copolymer, having an average molecular weight of 14,000 and a cloud point above 100 °C in 1 percent aqueous solution.
( b ) The additive is used or intended for use as follows: ( 1 ) The additive identified in paragraph (a)(1) of this section is used in practice as a solubilizing and stabilizing agent in flavor concentrates (containing authorized flavoring oils) for use in foods for which standards of identity established under section 401 of the Act do not preclude such use, provided that the weight of the additive does not exceed the weight of the flavoring oils in the flavor concentrate.
( 2 ) The additive identified in paragraph (a)(2) of this section is used as a processing aid and wetting agent in combination with dioctyl sodium sulfosuccinate for fumaric acid as prescribed in § 172.810.
( 3 ) The additive identified in paragraph (a)(3) of this section is used: ( i ) As a surfactant and defoaming agent, at levels not to exceed 0.05 percent by weight, in scald baths for poultry defeathering, followed by potable water rinse. The temperatures of the scald baths shall be not less than 125 °F.
( ii ) As a foam control and rinse adjuvant in hog dehairing machines at a use level of not more than 5 grams per hog.
( 4 ) The additive identified in paragraph (a)(4) of this section is used as a dough conditioner in yeast-leavened bakery products for which standards of identity established under section 401 of the Act do not preclude such use, provided that the amount of the additive dose not exceed 0.5 percent by weight of the flour used.
[42 FR 14491, Mar. 15, 1977, as amended at 46 FR 57476, Nov. 24, 1981]
A. L. B.

, M other of E.B.M. and

P.M.S.H., minor children,

Appellant,

v.

FLORIDA DEPARTMENT OF

CHILDREN AND FAMILIES

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEA RING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 16

- 1606

_____________________________/

Opinion filed August 22, 2016.

An appeal from the Circuit Court for Walton County

. Thomas R. Santurri, Judge

.

Appellant , pro se

.

Dwight O. Slater, Appellate Coun sel, Tallahassee for Department Children and

Families. Kelley Schaeffer of Guardian ad Litem Program, Sanford , for Appellee.

PER CURIAM.

AFFIRMED.

B. L. THOMAS, ROWE, and WINSOR, JJ., CONCUR.